Emilie Darrigues Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

ARA Fellow

University of Arkansas for Medical Sciences

faculty

9 h-index 13 pubs 265 cited

Research Areas

Glioblastoma Diagnosis and Treatment Cancer Genomics and Diagnostics Nanoparticle-Based Drug Delivery Immune Cell Function and Interaction Cancer-related molecular mechanisms research Precision Medicine Brain Tumor Biobank Development

Links

ORCID Lab Website

Edit your profile

OverviewAI-generated summary

Emilie Darrigues' research focuses on cancer biology, particularly glioblastoma, and the development of precision medicine models. She has investigated biobanked patient-derived organoids as a tool for studying glioblastoma invasion and developing targeted therapies. Her work also explores the genomic and transcriptomic profiling of brain metastases to inform treatment strategies. Darrigues has examined the role of specific genes, such as PCK2, in glioblastoma's impact on T cell metabolism. Additionally, her research has involved the use of gold nanorods to enhance immune cell function and target regulatory T cells. She collaborates with researchers at the University of Arkansas for Medical Sciences, including Analiz Rodriguez, Madison P. Lee, Annick De Loose, and Murat Gökden.

Metrics

h-index: 9
Publications: 13
Citations: 265

Selected Publications

1211 Defining the role of PCK2 in T cell metabolic plasticity in Glioblastoma (2023) DOI
Genomic and Transcriptomic Profiling of Brain Metastases (2021) DOI
Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion (2021) DOI
Gold nanorods enhance different immune cells and allow for efficient targeting of CD4+ Foxp3+ Tregulatory cells (2021) DOI
Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon (2021) DOI